Latest Radiation oncologist Stories
Prostate Cancer Treatment Specialist Stephen J. M. Banks, M.D., Has Joined the Martin-Oâ€™Neil Cancer Center Team at St. Helena Hospital. St. Helena, CA (PRWEB) August 12, 2011 St. Helena Hospitalâ€™s Martin-Oâ€™Neil Cancer Center (MOCC) welcomes Dr. Stephen J. M. Banks, M.D.
BOCA RATON and JUPITER, Fla., Aug.
VANCOUVER, British Columbia, July 28, 2011 /PRNewswire/ -- Varian Medical Systems' next release of the ARIAÂ® oncology information system, newly designed for greater ease of use, will be among the highlights of the company's exhibit at the 2011 joint meeting of the American Association of Physicists in Medicine (AAPM) and the Canadian Organization of Medical Physicists (COMP) here later this week.
PITTSBURGH, July 26, 2011 /PRNewswire/ -- D3 Oncology Solutions today announced that it will begin offering a comprehensive product to radiation oncologists and surgeons to rapidly but safely implement a successful SRS/SBRT program.
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.
Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels.
WASHINGTON, June 6, 2011 /PRNewswire-USNewswire/ -- A coalition of radiation oncology community leaders - representing thousands of patients, physicians, and manufacturers throughout the United States - commends Representatives Ed Whitfield (R-KY) and John Barrow (D-GA) for introducing the Consistency, Accuracy, Responsibility and Excellence (CARE) in Medical Imaging and Radiation Therapy Act in the House of Representatives (H.R.
Intensity modulated radiation therapy, a newer, more precise form of radiation therapy, causes fewer gastrointestinal side effects when combined with hormone therapy than using three-dimensional radiation therapy.
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors.
PITTSBURGH, May 24, 2011 /PRNewswire/ -- D3 Oncology Solutions today announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.